We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




BioConference Live to Focus on Clinical Diagnostics

By LabMedica International staff writers
Posted on 04 Oct 2010
BioConference Live offers the benefits of a conventional conference, with live keynote presentations, peer networking and an exhibit floor--over the web, so that attendees can participate from any computer, whether in their office, home, or teaching institution.

The upcoming edition of BioConference Live with its focus on clinical diagnostics will take place from 9:00 AM to 6:00 PM [U.S. More...
EDT] on Wednesday October 20, 2010, and on Thursday October 21, 2010.

On Wednesday, October 20, 2010, at 12:00 noon EDT, Alan Wu Ph.D., chief of clinical chemistry and toxicology and professor of laboratory medicine at San Francisco General Hospital (CA, USA) and University of California, San Francisco (CA, USA) will speak about the emerging role of pharmacogenomics in clinical research and practice. On the same day at 4: PM EDT Gyorgy Abel M.D. Ph.D., director of clinical immunology and molecular diagnostics at Harvard Medical School (Boston, MA, USA) will talk about human papillomavirus (HPV) molecular testing in cervical cancer screening.

On the following day, Thursday October 21st, 2010, at 9 AM James Nichols Ph.D., DABCC, FACB, medical director of clinical chemistry at Baystate Health (Springfield, MA, USA) and professor of pathology at Tufts University School of Medicine (Boston, MA. USA) will discuss point-of-care testing, what it is, and why everyone wants it. Later on Thursday, at 4:00 PM EDT Keith C. Ferdinand, M.D., FACC, FAHA, will talk about strategies for the management of hypertension. Dr. Ferdinand is the adjunct professor at Morehouse School of Medicine (Atlanta, GA, USA), and clinical professor, cardiology division at Emory University (Atlanta, GA, USA). He is also Chief Science Officer (CSO) for the Association of Black Cardiologists (ABC; Washington DC, USA).

An additional twenty speakers have been confirmed to participate in the BioConference Live program. To register to attend for free and to obtain a complete list of speakers and session topics visit BioConference Live (please see related links below).

The supporters of BioConference Live are Bio-Rad Laboratories (Hercules, CA, USA), Thermo Fisher Scientific (Waltham, MA, USA), the Ortho Clinical Diagnostics (Rochester, NY, USA) division of Johnson & Johnson, and Randox Laboratories (Antrim, UK).

The event producers are PlatformQ (Needham, MA, USA), a digital media company that produces virtual events in the education and healthcare markets, and Labroots, Inc., a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other.

Related Links:
BioConference Live


New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Automatic CLIA Analyzer
Shine i6000
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.